TrialAdvances in therapy2025

Multiple Switches Between Adalimumab-fkjp and Reference Adalimumab in Moderate-to-Severe Chronic Plaque Psoriasis: A Multicenter, Double-Blind, Parallel Group, Randomized Clinical Trial for Interchangeability.

Sarika Deodhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.